Manufacturer of Trasylol, Bayer AG, Finds Increased Risk of Death, Removes Trasylol from Shelves


by Legal - Date: 2007-11-14 - Word Count: 710 Share This!

On November 5, 2007, the manufacturer of a heart surgery drug, Bayer AG, pulled a heart surgery drug called Trasylol off of the shelves. The choice was made after medical regulation agencies pressured Bayer AG to remove the drug as a result of a Canadian study that found that Trasylol was connected with an increased risk of death for heart surgery patients who were given the drug. Despite the findings in the study, Bayer AG stated that it continues to believe that the drug is advantageous. Trasylol was tested by the Ottawa Health Institute along with two older antifibrinolytic drugs, but the study had to be stopped when it was found that patients who were given Trasylol exhibited a higher risk of death than patients given the two older drugs.

Antifibrinolytic drugs such as Trasylol are used during heart surgery because they slow the breakdown of blood clots during, and thus can prevent excessive bleeding. Unfortunately, the Food and Drug Administration has said that there are not many other choices for heart surgery patients who are risk for excessive bleeding. Thus, the FDA is working with Bayer to phase Trasylol out of the marketplace in a way that does not cause shortages of other drugs used for reducing bleeding during surgery. As a result of this, there will be no entire repeal of Trasylol at this point. However, these recent negative findings concerning Trasylol are only the next in a long line of safety concerns and warnings that have been documented by the FDA.

In September 2006, Bayer A.G. was faulted by the FDA for not revealing during testimony the existence of a commissioned retrospective study that concluded Trasylol carried potentially greater risks than other similar antifibrinolytic drugs. The FDA was alerted to the study by one of the researchers involved. Although the FDA issued a statement of concern they did not change their recommendation that the drug may benefit certain subpopulations of patients. On October 3, 2006, the FDA issued a Public Health Advisory Update recommendation that "physicians consider limiting Trasylol use to those situations in which the clinical benefit of reduced blood loss is necessary to medical management and outweighs the potential risks," and assiduously monitor the patients who have been given the drug. Drugs for heart surgery are limited and so, because of the necessity for these drugs, the FDA was hesitant about recommending a withdrawal of Trasylol, but it did issue a warning label for the drug in order to strengthen warnings concerning safety and using Trasylol.

This trend of potentially dangerous findings concerning Trasylol illustrates sometimes that once a drug is approved by the FDA, halting its sale is exceedingly difficult. Experts on FDA advisory panels are often hesitant to take widely used medicines out of doctors' hands, even when their safety is uncertain. For this reason it is important for anyone who may have had Trasylol used during a surgical procedure to consult with their doctor about the potential risks involved. The need for serious consultation concerning the safety of Trasylol is perhaps even more important for those who may potentially require Trasylol in a future surgical procedure.

For anyone who believes that, in addition to a medical consultation, they might require any kind of legal advice, contacting an experienced Trasylol law firm may be the best course of action. A Trasylol lawyer experienced in the intricacies of the complex situation involved in this case would be able to offer guidance and information to anyone who may have been affected, or who may have had a loved one affected. Getting in touch with an expert Trasylol attorney can be as easy as filling out the Trasylol lawyer case evaluation form at the top or bottom of this page. You can obtain any advice needed relating to a potential Trasylol lawsuit today!


------

For a source for everything legal on the web, you can always turn to LegalView.com. For admission to view a complete legal database which also includes a free attorney referral service, take a look around http://www.legalview.com . When using this service, visitors are able to utilize resources to make contact with attorneys concerning an array of legal issues such as a brain injury lawyer or a mesothelioma attorney. Site users can also find a Trasylol Aprotinin lawyer at http://trasylol-aprotinin.legalview.com/

Related Tags: tra, trasylol attorney, trasylol lawsuit, aprotinin, trasylol law firm, aprotinin law suit, aprotinin litigation, aprotinin law firm, aprotinin lawyer

Your Article Search Directory : Find in Articles

© The article above is copyrighted by it's author. You're allowed to distribute this work according to the Creative Commons Attribution-NoDerivs license.
 

Recent articles in this category:



Most viewed articles in this category: